Clinical Trial Update: Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients

View source ↗

Summary

Completed evaluation of immunogenicity and thrombotic potential of circulating protamine-heparin complexes in cardiac surgery patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Heparin (unfractionated heparin)
• Protamine sulfate (protamine sulfate)

Snippet

Sponsor: Medical University of Vienna | Conditions: Thrombocytopenia, Antibodies Drug Specific | Status: COMPLETED